` AMPH (Amphastar Pharmaceuticals Inc) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

AMPH
vs
NOVO B

Over the past 12 months, AMPH has outperformed NOVO B, delivering a return of -39% compared to the NOVO B's 56% drop.

Valuation Comparison

AMPH Intrinsic Value
42.83 USD
Undervaluation 42%
Intrinsic Value
Price
NOVO B Intrinsic Value
625.37 DKK
Undervaluation 28%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
24.67 USD
Novo Nordisk A/S
CSE:NOVO B
453.05 DKK

Financials Comparison

Growth Over Time
AMPH vs NOVO B

AMPH
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Amphastar Pharmaceuticals Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
AMPH vs NOVO B

AMPH
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

AMPH
50.5%
NOVO B
84.3%

Operating Margin

AMPH
26.7%
NOVO B
44.6%

Net Margin

AMPH
19.4%
NOVO B
34.5%

FCF Margin

AMPH
20.6%
NOVO B
24.5%

ROE

AMPH
19.9%
NOVO B
88.1%

ROA

AMPH
8.9%
NOVO B
26.6%

ROIC

AMPH
12.4%
NOVO B
30.4%

ROCE

AMPH
14.2%
NOVO B
70%

Stocks Performance

Stocks Performance
AMPH vs NOVO B

Loading
AMPH
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
AMPH vs NOVO B

Loading
AMPH
NOVO B
Difference
www.alphaspread.com

Performance By Year
AMPH vs NOVO B

Loading
AMPH
NOVO B
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account